论文信息 - A Phase 2 Clinical Study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a Fetal Hemoglobin Inducer, in Patients with Sickle Cell Disease - 字舞流文

A Phase 2 Clinical Study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a Fetal Hemoglobin Inducer, in Patients with Sickle Cell Disease

K. Ataga | A. Kutlar | P. Malik | A. Inati | A. Taher | M. Reid | J. White | A. El‐Beshlawy | R. Ghalie | M. Abboud | G. Buchanan | L. Neumayr | N. Koshy | Hedy P. Smith | Maria Aiello | Elizabeth Johnson